Bas Kreike

5.2k total citations
39 papers, 3.9k citations indexed

About

Bas Kreike is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Bas Kreike has authored 39 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cancer Research, 17 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Bas Kreike's work include Breast Cancer Treatment Studies (14 papers), Head and Neck Cancer Studies (10 papers) and Cancer Genomics and Diagnostics (8 papers). Bas Kreike is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Head and Neck Cancer Studies (10 papers) and Cancer Genomics and Diagnostics (8 papers). Bas Kreike collaborates with scholars based in Netherlands, United States and United Kingdom. Bas Kreike's co-authors include Marc J. van de Vijver, Britta Weigelt, Hugo M. Horlings, Jorge S. Reis‐Filho, Harry Bartelink, Marieke van Kouwenhove, Hans Peterse, Dimitry S.A. Nuyten, Rachael Natrajan and Hemant Ishwaran and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Bas Kreike

36 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bas Kreike Netherlands	25	2.1k	1.8k	1.8k	767	427	39	3.9k
Magali Lacroix‐Triki France	29	1.4k 0.7×	1.3k 0.7×	1.4k 0.8×	648 0.8×	476 1.1×	89	3.1k
Atilla Ömeroğlu Canada	23	1.9k 0.9×	1.6k 0.9×	1.7k 0.9×	779 1.0×	476 1.1×	74	4.0k
Thaer Khoury United States	32	1.1k 0.5×	1.5k 0.8×	1.1k 0.6×	675 0.9×	453 1.1×	153	3.1k
Paul van Diest Netherlands	23	1.0k 0.5×	1.4k 0.8×	1.5k 0.8×	513 0.7×	406 1.0×	49	3.2k
Wentao Yang China	34	1.2k 0.6×	1.7k 1.0×	1.4k 0.8×	553 0.7×	590 1.4×	173	3.8k
Ingunn M. Stefansson Norway	36	1.3k 0.6×	1.5k 0.8×	2.2k 1.2×	462 0.6×	552 1.3×	73	4.4k
Mohammed A. Aleskandarany United Kingdom	36	1.5k 0.7×	1.6k 0.9×	1.7k 0.9×	382 0.5×	510 1.2×	81	3.4k
Judith Hugh Canada	25	2.0k 1.0×	2.2k 1.2×	1.4k 0.8×	920 1.2×	701 1.6×	50	4.4k
Felipe C. Geyer United Kingdom	32	2.0k 0.9×	2.1k 1.2×	2.1k 1.1×	956 1.2×	697 1.6×	51	4.5k
Salvatore Piscuoglio Switzerland	39	2.7k 1.3×	1.7k 0.9×	2.5k 1.4×	861 1.1×	1.0k 2.4×	133	5.3k

Countries citing papers authored by Bas Kreike

Since Specialization

Citations

This map shows the geographic impact of Bas Kreike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas Kreike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas Kreike more than expected).

Fields of papers citing papers by Bas Kreike

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas Kreike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas Kreike. The network helps show where Bas Kreike may publish in the future.

Co-authorship network of co-authors of Bas Kreike

This figure shows the co-authorship network connecting the top 25 collaborators of Bas Kreike. A scholar is included among the top collaborators of Bas Kreike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bas Kreike. Bas Kreike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kreike, Bas, Abrahim Al‐Mamgani, Erik van Werkhoven, et al.. (2025). Postoperative radiotherapy for oral cavity cancer with or without elective neck radiotherapy of the pN0 en bloc dissected neck: oncologic outcomes and late toxicity. Radiotherapy and Oncology. 208. 110896–110896.

Bosch, Sven van den, Patricia Doornaert, Frank Hoebers, et al.. (2025). Dose de-escalation of elective neck irradiation in head and neck cancer: A secondary analysis of acute toxicity findings from the randomized controlled UPGRADE-RT trial. Radiotherapy and Oncology. 213. 111196–111196.

Bosch, Sandra van den, Patricia Doornaert, Bas Kreike, et al.. (2024). 3382: Safety and clinical benefit of reduced elective dose in head & neck cancer: results of a randomized controlled trial (NCT02442375). Radiotherapy and Oncology. 194. S1455–S1459. 1 indexed citations

Driessen, C.M.L., Mathijs P. Hendriks, E. Fiets, et al.. (2019). Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: A randomised phase 2 study. European Journal of Cancer. 113. 32–40. 10 indexed citations

Wildeman, Maarten A., Zlata Novalić, Renske Fles, et al.. (2015). Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group. European Archives of Oto-Rhino-Laryngology. 273(6). 1557–1567. 16 indexed citations

Servant, Nicolas, Marc A. Bollet, Hans Halfwerk, et al.. (2012). Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women. Clinical Cancer Research. 18(6). 1704–1715. 55 indexed citations

Natrajan, Rachael, Alan Mackay, Paul M Wilkerson, et al.. (2012). Functional characterization of the 19q12 amplicon in grade III breast cancers. Breast Cancer Research. 14(2). R53–R53. 62 indexed citations

Zhang, Haijun, Fanyan Meng, Bas Kreike, et al.. (2011). Engagement of I-Branching β-1, 6- N -Acetylglucosaminyltransferase 2 in Breast Cancer Metastasis and TGF-β Signaling. Cancer Research. 71(14). 4846–4856. 70 indexed citations

Farazi, Thalia A., Hugo M. Horlings, Jelle J. ten Hoeve, et al.. (2011). MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing. Cancer Research. 71(13). 4443–4453. 275 indexed citations

10.

Meng, Fanyan, Haijun Zhang, Gang Liu, et al.. (2011). p38γ Mitogen-Activated Protein Kinase Contributes to Oncogenic Properties Maintenance and Resistance to Poly (ADP-Ribose)-Polymerase-1 Inhibition in Breast Cancer. Neoplasia. 13(5). 472–IN25. 43 indexed citations

11.

Hartog, Hermien, Hugo M. Horlings, Bert van der Vegt, et al.. (2010). Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma. Breast Cancer Research and Treatment. 129(3). 725–736. 50 indexed citations

12.

López‐García, María Ángeles, Felipe C. Geyer, Rachael Natrajan, et al.. (2010). Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype‐matched ductal and lobular carcinomas. The Journal of Pathology. 222(1). 64–75. 27 indexed citations

13.

Kreike, Bas, Hans Halfwerk, Nicola J. Armstrong, et al.. (2009). Local Recurrence after Breast-Conserving Therapy in Relation to Gene Expression Patterns in a Large Series of Patients. Clinical Cancer Research. 15(12). 4181–4190. 68 indexed citations

14.

Wesseling, Jelle, Hermien Hartog, Hugo M. Horlings, et al.. (2009). Different effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple-negative invasive ductal breast carcinoma. Journal of Clinical Oncology. 27(15_suppl). 3546–3546.

15.

Mook, Stella, Marjanka K. Schmidt, Britta Weigelt, et al.. (2009). The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age. Annals of Oncology. 21(4). 717–722. 113 indexed citations

16.

Weigelt, Britta, Felipe C. Geyer, Rachael Natrajan, et al.. (2009). The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special type. The Journal of Pathology. 220(1). 45–57. 177 indexed citations

17.

Minn, Andy J., Gaorav P. Gupta, David Padua, et al.. (2007). Lung metastasis genes couple breast tumor size and metastatic spread. Proceedings of the National Academy of Sciences. 104(16). 6740–6745. 299 indexed citations

18.

Kreike, Bas, Hans Halfwerk, Petra Kristel, et al.. (2006). Gene Expression Profiles of Primary Breast Carcinomas from Patients at High Risk for Local Recurrence after Breast-Conserving Therapy. Clinical Cancer Research. 12(19). 5705–5712. 44 indexed citations

19.

Nuyten, Dimitry S.A., Bas Kreike, Augustinus A. M. Hart, et al.. (2006). Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Research. 8(5). R62–R62. 143 indexed citations

20.

Hannemann, Juliane, et al.. (2006). Classification of ductal carcinoma in situ by gene expression profiling. Breast Cancer Research. 8(5). R61–R61. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact